| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 36.233 | 29.446 | 19.397 | 4.919 | 10.256 | 31.959 | 39.859 | 163.391 | 249.125 | 201.281 |
| Total Income - EUR | 148.028 | 29.335 | 18.856 | 5.690 | 10.328 | 30.764 | 39.649 | 162.961 | 249.193 | 201.087 |
| Total Expenses - EUR | 269.905 | 127.778 | 95.989 | 54.969 | 120.002 | 28.418 | 39.165 | 73.815 | 69.326 | 118.491 |
| Gross Profit/Loss - EUR | -121.877 | -98.443 | -77.133 | -49.278 | -109.674 | 2.346 | 483 | 89.146 | 179.867 | 82.596 |
| Net Profit/Loss - EUR | -122.966 | -98.800 | -77.812 | -49.336 | -109.786 | 2.189 | 85 | 87.512 | 177.424 | 68.493 |
| Employees | 21 | 11 | 5 | 3 | 2 | 2 | 4 | 6 | 5 | 4 |
Check the financial reports for the company - Uromed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 794.713 | 836.068 | 786.606 | 738.359 | 693.148 | 678.836 | 661.555 | 663.694 | 712.810 | 747.523 |
| Current Assets | 36.079 | 16.391 | 14.056 | 15.214 | 68.830 | 66.511 | 80.520 | 98.814 | 29.482 | 94.428 |
| Inventories | 45.103 | 18.345 | 16.517 | 16.618 | 15.484 | 14.638 | 14.209 | 6.896 | 8.992 | 6.938 |
| Receivables | -9.446 | -3.547 | -6.591 | -3.620 | 51.973 | 48.947 | 54.028 | 9.241 | 8.591 | 12.738 |
| Cash | 422 | 1.594 | 4.130 | 2.216 | 1.373 | 2.925 | 12.283 | 82.676 | 11.898 | 74.752 |
| Shareholders Funds | 445.153 | 341.897 | 258.299 | 204.223 | 90.482 | 90.955 | 91.325 | 142.031 | 319.024 | 385.734 |
| Social Capital | 580.877 | 574.953 | 565.224 | 554.851 | 544.106 | 533.791 | 521.954 | 523.573 | 521.985 | 519.068 |
| Debts | 388.923 | 510.562 | 542.363 | 578.946 | 671.744 | 658.916 | 650.956 | 620.477 | 423.268 | 456.218 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "130 - 130" | |||||||||
| CAEN Financial Year |
130
|
|||||||||
Comments - Uromed Srl